In the context of fibrinolysis, PAIs inhibit the activity of plasminogen activators, such as tissue plasminogen activator ([tPA]()) and urokinase plasminogen activator ([uPA]()). This inhibition prevents the conversion of plasminogen to plasmin, a key enzyme responsible for breaking down fibrin clots. By regulating this process, PAIs help prevent excessive bleeding or inappropriate clot dissolution.
